PD-L1, Galectin-9 and CD8(+) tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma

Novel systemic treatments for hepatocellular carcinoma (HCC) are strongly needed. Immunotherapy is a promising strategy that can induce specific antitumor immune responses. Understanding the mechanisms of immune resistance by HCC is crucial for development of suitable immunotherapeutics. We used imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Sideras, Kostandinos, Biermann, Katharina, Verheij, Joanne, Takkenberg, Bart R., Mancham, Shanta, Hansen, Bettina E., Schutz, Hannah M., de Man, Robert A., Sprengers, Dave, Buschow, Sonja I., Verseput, Maddy C. M., Boor, Patrick P. C., Pan, Qiuwei, van Gulik, Thomas M., Terkivatan, Turkan, Ijzermans, Jan N. M., Beuers, Ulrich H. W., Sleijfer, Stefan, Bruno, Marco J., Kwekkeboom, Jaap
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353918/
https://www.ncbi.nlm.nih.gov/pubmed/28344887
http://dx.doi.org/10.1080/2162402X.2016.1273309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353918/
https://www.ncbi.nlm.nih.gov/pubmed/28344887
http://dx.doi.org/10.1080/2162402X.2016.1273309

Ejemplares similares